Equity
€2,000 from €150,398 in 2023
Equity fell by 99% in 2 years.
SBMed
Lifetime
5 annual accounts with figures on one time axispeak €227,119 (2025)
€227,119▲ 30.2%
peak €142,107 (2025)
€142,107▲ 90.5%
peak €150,398 (2023)
€2,000unchanged
€247,606▼ 15.8%
Board1 name since 2021
1 director
Documentsfilings and deeds
23-06-202654 days late
2025micro format
Gross margin from €174,407 to €227,119Result from €74,585 to €142,107Dividend €142,107Debts from €294,044 to €247,606Cash from €130,473 to €31,017
Key points
from the 2025 annual accountsResult
€142,107 ▲ 90.5%
The result rose in 2025 from €74,585 to €142,107.
Debts
€247,606 99% of the balance sheet
Financial debts 20%Suppliers 6%Taxes and wages 10%Other 64%
Of this, €197,045 falls due within a year.
2025 accounts filed 54 days after the deadline
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,153 companies had the same profile as SBMed has now. Each dot stands for 6 companies, two years later.
96.0%
were still trading
2.2%
stopped another way
1.7%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,153 companies, not a prediction for SBMed. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0765807872
Registered office moved from Seraing to Clermont-sous-Huy
New registered office: Aux Houx 39B, 4480 Clermont-sous-Huy · Previous registered office: Rue des Colombières 12 Boîte 21, 4101 Seraing · Board meeting of 22-06-2022 · Gazette deed
First establishment
Aux Houx 39, Engis
Incorporation
Founding capital of €2,000, 200 shares · Founder: · Appointment: (director) · published on 31-03-2021 · Gazette deed
Official details
Source: KBO- Status
- Active since 29-03-2021Normal situation
- Activity
- “Les honoraires sont perçus par et pour la société.” (deed in French)From the articles, 7 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.315.988.7274480 Engis, since 01-04-2021
- Financial year end
- 30 September
- Peppol
- Reachable since 12-02-2026
Insights on SBMed
SBMed files the micro format. That format states no turnover. The gross margin rose from €40,269 in 2021 to €227,119 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about SBMed
- What is the company number of SBMed?
- The company number of SBMed is 0765.807.872. The VAT number is the same number with BE in front: BE 0765.807.872.
- Where is SBMed based?
- The registered office is at Aux Houx 39B, 4480 Engis.Company details
- What is the legal form of SBMed?
- SBMed is a private limited company (BV).
- When was SBMed founded?
- SBMed was founded on 29-03-2021.
- Is SBMed still active?
- Yes, SBMed is an active enterprise in the KBO register.
- What is the turnover of SBMed?
- The turnover of SBMed was €306,621 in financial year 2025, according to the filed annual accounts.Financials
- Is SBMed profitable?
- In financial year 2025, SBMed made a profit of €142,107.
- Where can I find the annual accounts of SBMed?
- SBMed filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of SBMed due?
- SBMed must file the annual accounts for financial year 2026 by 30-04-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.